Innovation in Switzerland’s pharmaceutical industry has fallen for the second year in a row, a new study shows, underscoring how it is trailing foreign competitors in digital research and clinical trials.
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.